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Group B Streptococcus Late-Onset Disease:
2003–2010
WHAT’S KNOWN ON THIS SUBJECT: A minority of infants with
group B streptococcus (GBS) late-onset disease (LOD) are born to
GBS-colonized mothers. Intrapartum prophylaxis does not appear
to prevent late-onset GBS disease, implicating infected breast milk
and nosocomial or community sources in these cases.
WHAT THIS STUDY ADDS: Most mothers of neonates with LOD are
identiﬁed at diagnosis with anogenital GBS carriage. It seems
unlikely that GBS infected milk is a source of LOD in the absence
of mastitis. Intrapartum antibiotic prophylaxis is associated with
both delayed and milder presentation of LOD.
abstract
BACKGROUND: There is insufﬁcient population-based data on group B
streptococcus (GBS) late-onset disease (LOD). Risk factors and routes
of GBS transmission are poorly understood.
METHODS: A prospective, cohort study was conducted to collect inci-
dence data on LOD and evaluate GBS infections over an 8-year period
(2003–2010). Starting from January 2007, maternal rectovaginal and
breast milk cultures were routinely collected on conﬁrmation of the
LOD diagnosis to assess maternal GBS culture status.
RESULTS: The incidence rate of LOD was 0.32 per 1000 live births (1.4
and 0.24 per 1000 live births for preterm and term newborns, respec-
tively). The registered cases of LOD (n = 100) were classiﬁed as sepsis
(n = 57), meningitis (n = 36), or focal infection (n = 7). Thirty neonates
were preterm (2 had recurrent infection); 68 were term. Four infants
died (3 early preterm, 1 term). At the time the LOD diagnosis was
conﬁrmed, 3 (6%) of 53 mothers had GBS mastitis, and 30 (64%) of 47
carried GBS at the rectovaginal site. Early (7–30 days) LOD presenta-
tion was associated with neonatal brain lesions or death (odds ratio:
0.96 [95% conﬁdence interval: 0.93–0.99]). Intrapartum antibiotic ex-
posure was signiﬁcantly associated with mild (12 of 22) rather than
severe (11 of 45; P = .03) LOD.
CONCLUSIONS: Preterm neonates had the highest rates of LOD and
mortality. Most mothers carried GBS at the time of the LOD diagnosis,
whereas 6% had mastitis. Intrapartum antibiotics were associated
both with delayed presentation of symptoms and milder LOD. Pediat-
rics 2013;131:e361–e368
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Group B streptococcus (GBS) is a lead-
ing cause of neonatal sepsis and
meningitis. GBS infectionspresent from
birth to day 6 (early-onset disease
[EOD]) or from day 7 to 89 (late-onset
disease [LOD]).1 EOD is the result of
vertical transmission (at delivery or
shortly before) from a mother who is
colonized with GBS in the anorectal and
vaginal sites. Routine screening for
maternal GBS carriage in late preg-
nancy (35–37 weeks’ gestation) and
consequent intrapartum antibiotic pro-
phylaxis (IAP) have substantially reduced
the incidence rates of EOD.2
LOD can be acquired from the mother
(∼50% of infants with LOD are colonized
at birth with the same GBS serotype as
the mother)3 or from environmental
sources.1 The use of IAP for the pre-
vention of EOD has had no notable effects
on the occurrence of LOD. Data from the
United States have shown stable rates of
LOD (∼0.35 per 1000 live births), despite
widespread IAP administration.4
The pathogenesis of LOD is less well
understood than that of EOD, and in
some infants, the source of infection is
unclear. Nosocomial transmission of
GBS through the hands of health care
workers was frequent decades ago,
when postparturientmothers and their
infants typically remained in the hos-
pital for $1 week.5–7 Anecdotal case
reports have also suggested breast
milk as a possible source of GBS.8–13
However, it is unknown whether these
are currently common routes of LOD
transmission.
Risk factors may differ according to the
gestational age at birth. Therefore, LOD
pathogenesis might be dissimilar in
preterm and term neonates, and they
should be studied independently.
European LOD data are limited, and the
persistence of LOD after adoption of an
EOD preventive strategy has yet to be
investigated. A GBS prevention working
group was established in Emilia-
Romagna, Italy, in 2003. A screening-
based strategy was introduced,14 and
the incidence rates of EOD declined
from 0.29 to 0.19 per 1000 live births in
the period between 2003 and 2011 (A.B.,
unpublished data).
The current study was designed to
analyze LOD incidence and GBS-related
mortality and to determine maternal
culture status and clinical features in
both term and preterm newborns over
an 8-year period throughout an entire
regional network.
METHODS
Study Design
Since 2003, a prospective, population-
based study has been ongoing in
Emilia-Romagna, a region in Italy with
∼40 000 live births per year. The GBS
active surveillance network involves all
regional neonatal and pediatric depart-
ments and microbiologic laboratories.
The network provides continuous in-
formation on culture-proven infections
recorded in infants aged,90 days.15
A standardized form is used to collect
maternal and neonatal characteristics
for each GBS case; details include the
results of maternal rectovaginal cul-
tures at 35 to 37weeks of gestation, risk
factors, mode of delivery, IAP adminis-
tration, neonatal symptoms, age at
presentation, days of mechanical ven-
tilation, therapies, and outcome. As of
January 2007, additional information
(related to maternal mastitis, milk, and
rectovaginalcultures)hasbeenrequested
after conﬁrmation of the LOD diagnosis.
Infections recorded from January 1, 2003,
to December 31, 2010, are considered
here. All standardized forms were initially
analyzed by a single medical pro-
fessional (A.B.), but the data were
reviewed together with 2 additional
medical professionals (C.R. and L.L.).
Microbiologic Methods
Blood cultures were processed by us-
ing automated systems (Bactec 9240,
Becton Dickinson, Heidelberg, Germany;
Bactalert, bioMérieux, Craponne, France).
Milk samples were collected by man-
ual expression after both the breast
and the nipple had been washed with
soap and water and cleansed with
saline solution. After the initial drops
had been discarded, samples were
collected in a sterile container and
cultured on 5% deﬁbrinated sheep
blood, MacConkey, and Candida agar
plates.16 Bacterial strain characteriza-
tion was performed by using pulsed-
ﬁeld gel electrophoresis, according
to the standard method previously
reported.17
Study Deﬁnitions
GBS Case: Isolation of GBS from a nor-
mally sterile body site (eg, blood or
cerebrospinal ﬂuid [CSF]) in infants
aged 7 to 89 days.
Sepsis: Growth of GBS from blood cul-
ture associated with symptoms con-
sistent with sepsis.1
Meningitis: Presence of clinical symp-
toms associated with: (1) a positive
result on CSF culture; (2) a positive CSF
polymerase chain reaction; (3) a posi-
tive result on blood culture and CSF
pleocytosis (deﬁned as the presence of
.30 white blood cells/mm3 and ,45
000 red blood cells/mm3)18,19; or (4)
a positive result on CSF antigen testing.
Focal Infection: GBS-positive blood cul-
ture result associated with focal signs
outside the respiratory tract.
Mild Disease: Vague and short-lasting
symptoms, no need for mechanical
ventilation or catecholamine support,
and no clinical or laboratory evidence
of focal infection; infant discharged
from the hospital #7 days of disease
presentation.
Severe Disease: Includes any of the
following: death, meningitis, seizures,
brain lesions documented at hospital
discharge, need for catecholamine
support, or mechanical ventilation.
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Early Preterm: Includes neonates born
at ,34 weeks’ gestation.
Late Preterm: Includes neonates born
at 34 to 36 6/7 weeks’ gestation.
GBS Mastitis: Localized, painful in-
ﬂammation of the breast occurring in
conjunction with maternal ﬂulike
symptoms (eg, fever)20 and yield of GBS
in the milk culture.
Statistical Analyses
Analyses were performed by using
Stata/SE 11.2 for Windows (Stata Corp,
College Station, TX). Continuous varia-
bles were expressed as mean6 SD or
median and range; categorical data
were expressed as numbers (percen-
tages). Student’s t test and Levene’s test
for assessing homoscedasticity or the
Mann–Whitney rank sum test and x2
test or Fisher’s exact test were used
to compare, respectively, the contin-
uous and categorical variables be-
tween groups.
Severe brain lesions and death were
considered as the most severe com-
plicationandwere studiedat univariate
and multivariate analyses. Mechanical
ventilation or catecholamine support
were not included in this composite
outcome because they are risk factors
for developing brain lesions or death;
furthermore, the decision to use me-
chanical ventilation or catecholamine
support may sometimes be based on
subjective rather than objective crite-
ria.
No correlated variables reaching a P
value ,.1 in univariate analysis were
included in the multivariate logistic
regression model. The accuracy of
the model was veriﬁed by using the
Hosmer-Lemeshow goodness-of-ﬁt test.
All P values refer to 2-tailed tests of
signiﬁcance. P , .05 was considered
signiﬁcant and .10 , P , .05 was
considered as an indication of a trend.
RESULTS
A total of 100 LOD cases (98 newborns
[2 early preterm newborns had re-
current infection]) were registered
across the region during the study
period. The incidence was 0.32 per
1000 live births, with no signiﬁcant
variations occurring in the rates of
infection over the 8-year study period.
Table 1 presents incidence data ac-
cording to gestation period for the
entire region. Compared with term
neonates, early preterm newborns
had an increased risk of contracting
LOD (odds ratio [OR]: 16.3 [conﬁdence
interval (CI): 10.2–26.2]).
Maternal Data
Sixty-one of the 98 mothers had a vagi-
nal delivery and 37 had a cesarean
delivery; in the latter group, 20 (6 pre-
term and 14 term births) were not in
labor and had intact membranes.
Twelve mothers had prolonged mem-
brane rupture, 3 had GBS bacteriuria,
and 1 had intrapartum fever ($38°C).
Risk factor data were missing for 25
mothers: GBS bacteriuria (22 cases [11
preterm]), prolonged membrane rup-
ture (2 cases), and maternal intra-
partum temperature (1 case).
Table 2 provides information on ante-
natal screening and IAP administration
for the 98 mothers included in the
study. The table gives also additional
information (maternal GBS carriage,
milk cultures, and mastitis data) ac-
quired after conﬁrmation of the LOD
diagnosis. This information was rou-
tinely collected starting from January
2007 and relates to 53 of the 98mothers.
Vaginal cultures taken both after the
diagnosis of LOD (n = 47) and during
antenatal screening (n = 40) were
compared. Mothers of affected neo-
nates were more likely to be carrying
GBS at the time of the LOD diagnosis (30
of 47 cases) than at the time of antenatal
screening (13 of 40 cases) (P, .01).
TABLE 1 Incidence and Gestation Period for LOD Cases, Contextualized With Data for the Entire Region
Regional Dataa
Gestation period Live Births
Regional live births during the study period (2003–2010), n 311 893
Full-term births, $37 wk’ gestation, n (% of all regional live births) 288 727 (92.6)
Preterm births, ,37 wk’ gestation, n (% of all regional live births) 23 166 (7.4)
Early preterm births, ,34 wk’ gestation, n (% of all regional live births) 6012 (1.9)
Late preterm births, 34–36 6/7 wk’ gestation, n (% of all regional live births) 17 154 (5.5)
Study Data
Neonatal LOD infections Cases Incidence/1000 Live Births (95% CI)
Cases, n 100 0.32 (0.25–0.38)
Term newborns, n 68 0.24 (0.18–0.29)
Preterm newborns, n 32b 1.4 (0.9–1.8)
Early preterm newborns, n 23b 3.8 (2.3–5.4)
Late preterm newborns, n 9 0.5 (0.2–0.9)
a Data were obtained from the Regional Health Agency hospital discharge charts. Starting from January 2008 a province outside the region (Belluno, approximately 800 live births/year) was
added to the surveillance area.
b Of 30 preterm infants, 2 early preterm infants had a single recurrent infection.
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GBS status was known both at the time
of antenatal screening and at the di-
agnosis of LOD in 30 of the 53 mothers.
Among them, 10 mothers were per-
manently culture-negative and 20 were
culture-positive at least once.
Milk samples were taken for culture
from 44 of 45 breastfeeding mothers, 3
of whom had mastitis. Of the 11 milk
cultures with results positive for GBS,
a bacterial count was available for 6. In
the 3 cases of mastitis, the bacterial
count was $1 000 000 colony-forming
unit/mL, and in the 3 cases without
mastitis, the bacterial count was#100
000 colony-forming unit/mL.
Neonatal Data
Among the 98 newborns, 30 were pre-
termand 68were term. Seven neonates
were of African descent, 4 were Asian,
and 4 were South American. The mean
gestational age at delivery was 36.36
4.6 weeks (range: 24–38 weeks), and
the mean birth weight was 2711 6
1000 g (range: 630–5210 g).
Of the 100 LOD cases, 57 (57.0%) were
classiﬁed as sepsis, 7 (7.0%) as focal (4
arthritis, 2 cellulitis, and 1 adenitis),
and 36 (36.0%) as meningitis (CSF
obtained in 60 [60.0%] of 100 cases).
Four infants with sepsis and 2 with
meningitis also had pneumonia.
Of the 36 cases of meningitis, 9 (25.0%)
had sterile blood cultures, whereas 27
(75.0%)hadboth sepsis andmeningitis.
Thirty cases were CSF culture-proven,
whereas 6 had GBS-positive blood cul-
tures and abnormal CSF parameters (5
cases of CSF pleocytosis, 1 case of CSF-
positive antigen).
Fifteen newborns (15.0%) presented
with severe brain lesions at hospital
discharge; 14 of them suffered from
meningitis and were born at term.
Factors Associated With an Earlier
LOD Presentation
Term infants were younger at LOD
presentation (mean: 29.8 days; median:
23.0 days; interquartile range (IQR):
14.5–42.0) than preterm neonates
(mean: 41.4 days; median: 39.0 days;
IQR: 27.5–57.5; P , .01).
Newborns without IAP exposure were
more likely to be younger at LOD pre-
sentation (meanage: 29.0 days;median:
24.0 days; IQR: 15.0–41.0; OR for early
presentation: 4.3 [95% CI: 1.7–10.8])
than newborns receiving IAP for any
length of time (mean age: 43.6 days;
median: 40.0 days; IQR: 25.0–62.0; P ,
.01).
Considering only infants who under-
went a lumbar puncture, meningitis
(withorwithoutsepsis)presented itself
signiﬁcantly earlier (mean: 26.6 days;
median: 19.0 days; IQR: 13.0–34.5) than
sepsis alone (mean: 32.87 days; median
days: 29.5; IQR: 19.0–43.0; P = .04).
In multivariate logistic regression anal-
ysis, the presence of brain lesions or
death was associated with early (7–30
days) presentation of LOD (53 cases,
OR: 0.96 [95% CI: 0.93–0.99]) and an
abnormal (,5000 or .30 000/mm3)
white blood cell count at the time of the
LOD diagnosis (23 cases, OR: 3.61 [95%
CI: 1.08–2.09]).
LOD Severity
Sixty-sevenLODcaseswereclassiﬁedas
mild or severe (22 mild, 45 severe). The
remaining 33 LOD cases did not meet
inclusion criteria for either deﬁnition.
IAP exposure was signiﬁcantly associ-
ated with mild (12 of 22) rather than
severe (11 of 45; P = .03) LOD. Severe
LOD presented itself signiﬁcantly ear-
lier (mean: 28.6 days; median: 20.0
days; IQR: 14.0–39.0) than mild disease
(mean: 44.6 days; median: 45.5 days;
IQR: 30.0–60.0; P , .01).
Infants Presenting With LOD Before
Hospital Discharge
Fifteen preterm infants were still in-
patients when diagnosed with LOD.
Maternal GBS status at the time of the
LOD diagnosis was assessed in 6 cases,
and4of the6motherswereGBSculture-
positive.
Inpatients were compared with out-
patients born either preterm or term
(Table 3). Inpatients had a lower birth
TABLE 2 Cultures of the 98 Mothers Included in the Study and Intrapartum Prophylaxis
Administration
Variables 2003–2006 (n = 45) 2007–2010 (n = 53)
Preterm
(n = 16)
Term
(n = 29)
Preterm
(n = 14)
Term
(n = 39)
Antenatal screening, n 5 21 3 37
GBS culture-positive, n 2 3 0 13
Any indication for IAP, na 13 4 11 14
Women exposed to IAP, n 6 3 6 17
Adequate prophylaxis, nb 5 3 3 8
Rectovaginal cultures (at LOD diagnosis), n — — 12 35
GBS culture-positive mothers, n — — 9 21
GBS status known, nc — — 2 28
Permanently culture-negative mothers, n — — 1 9
Culture-positive at least once, n — — 1 19
Breastfeeding mothers (at LOD diagnosis), n — — 11d 34
Milk cultures, n — — 11 33
Culture-positive milk, n — — 2 9
GBS mastitis, n — — 1 2
a GBS carriage or risk factors without antenatal screening.
b Intrapartum antibiotic administration (penicillin, ampicillin, or cefazolin) at least 4 hours before
delivery (according to Verani et al2).
c GBS status was “known” if cultures were obtained both at the time of screening and after
conﬁrmation of the LOD diagnosis.
d Milk was pump-extracted from 6 of the 11 mothers (GBS-infected milk in 2 cases).
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weight, younger gestational age, and
were more often treated with broad-
spectrum antibiotics in the postpartum
period. Compared with outpatients born
at term, inpatients required more cate-
cholamine support and mechanical
ventilation and were at the highest risk
of mortality.
GBS Outbreak
Of the 15 inpatients, 3 were infected
during a 2-week outbreak in a NICU (7
rooms, ∼500 admissions per year, of
which ∼70 were very low birth weight
newborns). The index case was an
outpatient male preterm neonate (34
weeks’ gestation, birth weight 1830 g)
born to a culture-negative mother. Due
to maternal hypertension, the infant
was delivered by a cesarean delivery
with intact membranes. The clinical
course was uneventful, and he was
discharged at day 17, but the newborn
was readmitted to the NICU after 72
hours because of GBS meningitis.
Results of the rectovaginal culture
collected from his mother after the
conﬁrmation of LOD were negative.
The newborn was admitted to a single-
bed room but placed under the care of
nursing staff whowere also assigned to
an adjacent 6-bed room. Within the next
2 weeks, 3 inpatient preterm newborns
(2 of whom were early preterm [birth
weight 990 and 820 g, respectively] and
1 was late preterm [birth weight 1550
g]) presented with LOD (2 cases of
sepsis, 1 of meningitis).
Two of three preterm mothers were
culture-negative at delivery, whereas
theplacental cultureof the thirdmother
yielded GBS. These 3 infants plus the
index case were culture-negative at
birth; 2 of them were exposed to ad-
equate IAP and broad-spectrum anti-
biotics in the postpartum period.
Pulsed-ﬁeld gel electrophoresis analy-
sis was performed for the index case
and 3 inpatient preterm newborns. The
analysis demonstrated that the GBS
strains were indistinguishable.
Of the 38 newborns subsequently ad-
mitted to the NICU and screened in the
next 4 weeks, 5 preterm neonates were
identiﬁed as asymptomatic and GBS
colonized.
Further GBS transmission was suc-
cessfully prevented through control
measures such as surveillance cul-
tures of infants, cohorting of all colo-
nized and infected newborns, reliance
on dedicated nursing staff, careful
hand-washing, and infection control
practices.
DISCUSSION
Population-based LOD data in the lit-
erature varies greatly.21 LOD incidence
in Europe ranges from 0.10 to 0.24 per
1000 live births (an incidence 1.5–4
times lower than that associated with
EOD), and LOD case fatality rates range
from 2% to 8%.21–28
In the available literature, low birth
weight has been associated with an
increased risk of GBS infection. The
underrepresentation of low birth
weight neonates (,20%) in a study
sample can lead to a substantial un-
derestimation of the disease.24
The current study included a high
percentage of preterm newborns. The
relatively high LOD incidence rate
(0.32 per 1000 live births) is compa-
rable to that reported in the Active
Bacterial Core surveillance areas of
the United States (0.32–0.36 per 1000
live births) during the era of univer-
sal screening.4
GBS status was most commonly known
in mothers who delivered term infants;
,30% of them had positive culture
results at the time of antenatal
screening, but higher rates of GBS
carriage were found after the di-
agnosis of LOD. The authors have pre-
viously reported that GBS strains
cultured from both mothers and
infants at the time of the LOD diagnosis
were indistinguishable according to
molecular typing in all examined cases.17
False-negative screening results and
a change ofmaternal culture status after
screening may explain the higher rates
TABLE 3 Comparison of Infants Presenting With LOD Before (Inpatients) or After (Outpatients) Hospital Discharge
Characteristic Inpatients (n = 15) Outpatients, Born Preterm (n = 15) Outpatients, Born Term (n = 68) Pa Pb
Birth weight, median, g (IQ) 980 (860–1190) 1860 (1602–2175) 3195 (2932–3570) ,.01 ,.01
Gestational age at delivery, median, wk (IQ) 27 (26.0–29.7) 33 (31.0–34.0) 39 (38.0–40.0) ,.01 ,.01
Age at LOD diagnosis, median, d (IQ) 39 (21.7–47.0) 39 (30.5–58.7) 23 (14.5–42.0) .57 .08
IAP exposure, n (%) 5 (33.3) 7 (46.7) 20 (29.4) .71 .99
Postpartum antibiotics, median, d (IQ)c 7 (4.2–7.7) 0 (0.0–6.5) 0 (0.0–0.0) .03 ,.01
Meningitis (6 sepsis), n (%)d 3 (50.0) 4 (36.4) 29 (67.4) .98 .70
Catecholamine support, n (%) 4 (36.4) 2 (13.3) 3 (4.4) .66 .02
Mechanical ventilation, n (%) 8 (53.3) 2 (13.3) 5 (7.4) .05 ,.01
Brain lesions at hospital discharge, n (%)e 0 1 (6.7) 14 (20.6) .46 .12
Mortality, n (%) 3 (20.0) 0 1 (1.5) .22 .02
a Comparison between inpatients and preterm outpatients.
b Comparison between inpatients and term outpatients.
c All infants administered broad-spectrum antibiotics in the postpartum period before LOD presentation.
d Comparison includes only newborns who had a lumbar puncture (6 inpatient and 54 outpatient neonates, of whom 11 were preterm and 43 were term).
e Lesions were: hydrocephalous (n = 3), white matter damage (n = 3), white matter and cortex damage (n = 6), white matter and basal ganglia damage (n = 2), and unspeciﬁed lesions (n = 1).
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of maternal GBS carriage at the time of
the LOD diagnosis.
More than one-half of the women who
were culture-positive at the time of
antenatal screening received IAP. How-
ever, GBS may persist for many weeks
after antibiotic therapy,29 and mothers
therefore remain an important source
of transmission.
Only one-third of mothers whose cul-
ture status was examined both during
antenatal screening and at the time of
the LOD diagnosis were permanently
culture-negative. Transmission from
anosocomial orcommunity sourcemay
be suspected.
Case reports have implicated infected
breast milk as a possible cause of LOD,
with8–10 or without the occurrence of
mastitis.11–13 Mastitis results in a mas-
sive GBS milk inoculum, which may
lead to heavy neonatal colonization,
a known risk factor for invasive GBS
infections.1 In the current study, 6% of
mothers had mastitis, and they had the
highest bacterial counts. Most GBS-
infected milk samples were obtained
from mothers without mastitis, who
had the lowest bacterial counts.
Themost common clinical presentation
of LOD was sepsis, followed by menin-
gitis and focal infection. Meningitis was
the main cause of brain lesions in term
infants.
The earlier LOD presented itself, the
higher was the risk for meningitis and
death. Furthermore, IAP administration
was found to be associated both with
delayed LOD presentation and with
milder LOD. The reason for this asso-
ciation is unclear. However, IAP expo-
sure might change the routes of GBS
transmission (ie, from vertical to hor-
izontal), leading to less heavy neonatal
colonization and less severe LOD.
One-half of the preterm newbornswere
inpatients at the time they were di-
agnosed with LOD. A few mothers had
cultures; most of them were found to
carry GBS at the vaginal site at the time
the diagnosis of LOD was conﬁrmed.
Thus, the source of GBS for inpatients
may not necessarily be nosocomial.
Newborns who were inpatients at the
time of onset had a lower birth weight,
younger gestational age, and more
severe disease. Possible reasons for
increased susceptibility to severe LOD
include immature immune responses
and the many invasive devices used to
provide life-supporting care. The new-
borns were also more likely to receive
broad-spectrum antibiotics in the post-
partum period. Antibiotics may alter
infant bacterial ﬂora,30 and an associa-
tion between late-onset sepsis and
broad-spectrum antibiotics after day 3
in very low birth weight newborns has
been documented previously.31
Reports of GBS outbreaks have recently
become uncommon.32,33 Vertical trans-
mission from culture-positive carrier
women is less common after the in-
troduction of IAP; therefore, the oc-
currence of cross-transmission in the
obstetrics ward is likely to be rarer
than in the past.
In this study, the index case of the GBS
outbreak was infected by a non-
maternal source (before or soon after
hospital discharge). After GBS was in-
troduced into the NICU, 3 inpatient
preterm newborns (who had negative
culture results at birth) were infected
with the same strain. The infection
wasprobably transmitted through the
hands of health care workers and was
brought successfully to a halt through
the implementation of adequate dis-
ease control measures. Clinicians and
nurses must be aware of the potential
nosocomial spread of invasive patho-
gens within NICUs, and hospital in-
fection control recommendations must
be rigorously followed.
This study has a number of limitations.
Although information on maternal GBS
carriage and mastitis at the time of LOD
diagnosis was routinely obtained start-
ing from 2007, bacterial counts of milk
cultures were available for fewmothers
without mastitis. The extent to which
milkcontaminationcouldbearisk factor
for LOD therefore cannot be quantiﬁed.
Furthermore, most mothers who de-
livered preterm had unknown GBS
status before delivery. As a result, the
source of GBS was unclear for most
infected infants who were still inpa-
tients when diagnosed with LOD.
CONCLUSIONS
The main source of neonatal infection
was the mothers themselves, and IAP
exposurewas insufﬁcient toprevent the
transmission of GBS to the newborn.
Conjugate vaccines, currently at ad-
vanced stages of testing, may be the
most attractive strategy for future
prevention.
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